17:33 , Jul 17, 2018 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Sarcoma Mouse studies suggest vaccines based on R123H-mutant IDH1 could help treat sarcomas harboring the mutation. In a syngeneic mouse model of sarcoma expressing the IDH1 R132H mutation, vaccination with a R132H-mutant IDH1 peptide decreased...